Therapeutic Options for the Treatment of Coronavirus Disease (COVID-19). Issue 4 (October 2020)

• Record Type: Journal Article
• Authors: Snawerdt, Jessica; Finoli, Lauren; Bremmer, Derek N.; Cheema, Tariq; Bhanot, Nitin
• Is Part Of: Critical care nursing quarterly. Volume 43:Issue 4(2020)
• Publication Date: 2020-10
• Subjects: antimalarial agents -- antivirals -- COVID-19 -- SARS-CoV-2 -- treatment; Critical care medicine -- Periodicals; Intensive care nursing -- Periodicals; Education, Nursing, Continuing -- Periodicals; Critical Care -- Periodicals; Emergencies -- Periodicals; 616.028
• DOI: 10.1097/CNQ.0000000000000321
• Languages: English
• ISSNs: 0887-9303

Abstract

Abstract : Coronavirus disease 2019 (COVID-19) has resulted in an unprecedented pandemic, challenging practitioners to identify safe and effective therapeutic options in a limited amount of time. The rapid genomic sequencing of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) provided a significant number of therapeutic targets. Repurposed and investigational agents are being studied for use in COVID-19. Although knowledge is rapidly expanding in regard to COVID-19 and there is promise with a few agents, there are no definitely proven effective therapies at this time. Supportive care remains the mainstay of therapy while ongoing clinical trials are being conducted.